Hemosate Ultra Hs1125 6.91 g (Citric Acid SOLUTION) 6.91 G

HEMOSATE ULTRA HS1125 6.91 G is a citric acid solution designed for haemodialysis. This product is manufactured by Chief Medical Supplies Ltd. in Canada, ensuring quality and reliability for medical use.

Strength

6.91 G

Manufacturer / TM Owner

CHIEF MEDICAL SUPPLIES LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

HEMOSATE ULTRA HS1125 6.91 G is primarily used in haemodialysis procedures. Citric acid solutions like this one are often utilized to maintain the pH balance in dialysis fluids, supporting the overall effectiveness of the treatment. Understanding what citric acid is used for in medical settings can help healthcare professionals ensure proper application.

Side Effects

When used as directed, citric acid solutions can help stabilize the pH levels in dialysis fluids. This can contribute to a more comfortable and effective haemodialysis process. Common effects may include improved fluid balance and reduced risk of complications during treatment.

Precautions & Warnings

It is important to handle citric acid solutions with care, following all safety guidelines provided by the manufacturer. Ensure proper storage conditions to maintain the integrity of the solution. Always consult healthcare professionals for specific handling instructions and precautions.

Avoid Interactions

Citric acid solutions may interact with certain medications or substances. It is advisable to inform healthcare providers about all current medications to avoid potential interactions. Additionally, always follow the recommended usage guidelines to minimize any risks.

Frequently Asked Questions

HEMOSATE ULTRA HS1125 6.91 G is used in haemodialysis to help maintain the pH balance in dialysis fluids.

Store citric acid solutions in a cool, dry place away from direct sunlight and heat sources.

Yes, citric acid solutions may interact with certain medications. Always consult a healthcare professional for advice.

Common effects include improved fluid balance and reduced risk of complications during treatment.

HEMOSATE ULTRA HS1125 6.91 G is manufactured by Chief Medical Supplies Ltd. in Canada.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.